SCHEMBL2482875

SCHEMBL2482875

COC(=O)c1c(O)c2c(C)cccc2[nH]c1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.52
ALDH1A1 P00352 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HPGD P15428 2/20 0.52
HSD17B10 Q99714 1/20 0.52
USP2 O75604 1/20 0.47
NR4A2 P43354 2/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
MAP3K5 Q99683 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
DAO P14920 1/20 0.44
DDO Q99489 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3981085 0.86 MEN1 (0.51) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL2483507 0.83 KDM4E (0.50) KDM4EALDH1A1KMT2AHPGDHSD17B10
SCHEMBL1882573 0.82 KDM4E (0.47) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL321280 0.82 USP2 (0.44) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL322275 0.82 USP2 (0.44) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL321856 0.80 KDM5A (0.44) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL1622313 0.79 KDM4E (0.71) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL30681958 0.79 KDM4E (0.71) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL5304938 0.77 KDM4E (0.51) KDM4EALDH1A1MEN1KMT2AUSP2
SCHEMBL31146219 0.76 KDM4E (0.53) KDM4EALDH1A1KMT2AHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376456-A2 HIGHLY PURE LAQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Actavis Group Ptc Ehf (IS) 2011-10-19 EP claimed
WO-2010070449-A2 HIGHLY PURE LAQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ACTAVIS GROUP PTC EHF (IS) 2010-06-24 WO claimed
EP-2376456-A2 HIGHLY PURE LAQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Actavis Group Ptc Ehf (IS) 2011-10-19 EP disclosed
WO-2010070449-A2 HIGHLY PURE LAQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ACTAVIS GROUP PTC EHF (IS) 2010-06-24 WO disclosed